Prognostic significance of SLC9A9 in patients with resectable esophageal squamous cell carcinoma.

Tumour Biol 2015 Sep 3;36(9):6797-803. Epub 2015 Apr 3.

State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.

The survival rate of esophageal squamous cell cancer (ESCC) patients is still dismal. Therefore, novel prognostic biomarkers are critically needed for patients with ESCC. SLC9A9 has been reported to be downregulated in hormone-sensitive prostate cancer; however, the correlations between SLC9A9 and ESCC prognosis are unclear. The aim of this study is to evaluate the expression and prognostic significance of SLC9A9 in resectable ESCC. Fresh frozen or paraffin-embedded samples were collected from 167 or 59 patients with resectable ESCC, respectively. The expression of SLC9A9 was assessed by reverse transcription and quantitative real-time polymerase chain reaction analysis (167 patients) and immunohistochemistry (61 patients). The expression of SLC9A9 was not associated with patient clinicopathological characteristics at both transcription and protein levels. The 5-year overall survival in the high SLC9A9 messenger RNA (mRNA) group (n = 106) was poorer than that in the low expression group (n = 61) (34.6 vs. 65.9 %, P < 0.001). Notably, higher SLC9A9 protein expression was also correlated with lower 5-year overall survival (33.1 vs. 66.5 %, P = 0.023). Moreover, multivariate analysis revealed that SLC9A9 mRNA (HR, 2.41; 95 % CI, 1.47-3.97; P = 0.001) and protein (HR, 2.31; 95 %CI, 1.06-5.02; P = 0.034) were independent prognostic factors. In conclusion, the expression of SLC9A9 can be a prognostic predictor for ESCC.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13277-015-3392-4DOI Listing
September 2015
9 Reads

Publication Analysis

Top Keywords

167 patients
8
esophageal squamous
8
resectable escc
8
squamous cell
8
expression slc9a9
8
patients resectable
8
prognostic significance
8
significance slc9a9
8
slc9a9
7
patients
6
escc
5
transcription quantitative
4
reverse transcription
4
quantitative real-time
4
assessed reverse
4
polymerase chain
4
analysis 167
4
patients immunohistochemistry
4
reaction analysis
4
chain reaction
4

References

(Supplied by CrossRef)

R Siegel et al.
CA Cancer J Clin 2014

PC Enzinger et al.
N Engl J Med 2003

J Orlowski et al.
Pflugers Arch 2004

K Tamura et al.
Cancer Res 2007

D Ng et al.
Int J Cancer 2008

S Harguindey et al.
Biochim Biophys Acta 2005

J Liu et al.
Ann Thorac Surg 2012

S Saussez et al.
Ann Surg Oncol 2006

TW Rice et al.
Dis Esophagus 2009

XL Xu et al.
Med Oncol 2015

S Ma et al.
Oncol Rep 2014

Similar Publications